Nefense, a company specializing in clinical hygiene and airway health, has announced the official launch of its Hypochlorous Acid (HOCl) nasal spray line. The new product range, detailed in a press release, introduces an age-specific approach to nasal care, with separate formulations for adults, children, and infants. This expansion aims to address respiratory hygiene and nasal wellness across different life stages.
The flagship product, Hyponasal, utilizes hypochlorous acid to provide a gentle yet effective biocleanse. According to the company, the spray flushes irritants, delivers soothing relief, and supports natural respiratory defenses without relying on harsh chemicals or steroids. Hypochlorous acid is known for its broad-spectrum antimicrobial and anti-inflammatory properties, which can neutralize bacteria and viruses, help prevent upper respiratory infections, and combat seasonal allergies.
Nefense emphasizes that the product line was developed in collaboration with doctors and ENT specialists, bridging the gap between daily hygiene, airway health, and overall wellness. The company already offers XyloClean, a xylitol-based nasal spray, as part of its growing portfolio. Many clinics and practices nationwide provide in-store purchases of the Nefense nasal spray family.
The launch underscores a growing trend toward non-pharmaceutical interventions for respiratory health. By tailoring formulations to different age groups, Nefense addresses a key need: safe and effective nasal care for vulnerable populations, including infants. The availability of clinical-grade HOCl sprays could offer an alternative to conventional treatments for allergy and infection prevention.
For more information, the full announcement with downloadable images and bios is available here.
